2022
DOI: 10.1186/s12935-022-02703-x
|View full text |Cite
|
Sign up to set email alerts
|

Mucosal-associated invariant T cells predict increased acute graft-versus-host-disease incidence in patients receiving allogeneic hematopoietic stem cell transplantation

Abstract: Background Mucosal-associated invariant T (MAIT) cells are innate-like T cells, some studies have reported that the number of circulating MAIT cells reduced in patients with acute graft-versus-host-disease (aGVHD) development. However, the role of donor MAIT cells on aGVHD development and subsequent functional change still remain unclear. Methods The study recruited 86 patients with hematological malignancies who underwent allogeneic hematopoietic … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
8
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(8 citation statements)
references
References 53 publications
0
8
0
Order By: Relevance
“…S2B). CI of aGvHD and grade II-IV aGvHD did not differ significantly among different types of HSCT: 31% (95%CI 20-45) vs 22% (95%CI [15][16][17][18][19][20][21][22][23][24][25][26][27][28][29][30][31][32] and 21% (95%CI 12-35) vs 18% (95%CI 11-28) in MUD and Haplo-HSCT, respectively, p=0.27 and p=0.78). Similar results among the two groups were also observed analyzing cGvHD occurrence: 5 MUD-HSCT and 10 Haplo-HSCT experienced cGvHD (CI 10%, 95%CI 4-22, vs 12%, 95%CI 6-21, respectively, p=0.66), with a CI of moderate/severe cGvHD of 8%, 95%CI 3-20, vs 8%, 95%CI 4-17, respectively, p=0.85.…”
Section: Patients and Outcomementioning
confidence: 89%
See 1 more Smart Citation
“…S2B). CI of aGvHD and grade II-IV aGvHD did not differ significantly among different types of HSCT: 31% (95%CI 20-45) vs 22% (95%CI [15][16][17][18][19][20][21][22][23][24][25][26][27][28][29][30][31][32] and 21% (95%CI 12-35) vs 18% (95%CI 11-28) in MUD and Haplo-HSCT, respectively, p=0.27 and p=0.78). Similar results among the two groups were also observed analyzing cGvHD occurrence: 5 MUD-HSCT and 10 Haplo-HSCT experienced cGvHD (CI 10%, 95%CI 4-22, vs 12%, 95%CI 6-21, respectively, p=0.66), with a CI of moderate/severe cGvHD of 8%, 95%CI 3-20, vs 8%, 95%CI 4-17, respectively, p=0.85.…”
Section: Patients and Outcomementioning
confidence: 89%
“…An increasing number of studies have investigated the role of MAIT cells during immune reconstitution following allo-HSCT. It has been reported that MAIT cell recovery is primarily graftderived after transplantation and that a higher proportion of MAIT cells in the graft is associated with a greater incidence of acute GvHD (aGvHD) 17,18 . Previous studies also suggested that reduced post-HSCT MAIT cell count is associated with the development of aGvHD [18][19][20] .…”
Section: Mucosal-associated Invariant T (Mait) Cells Are Innate-like ...mentioning
confidence: 99%
“…Innate T cells, as previously noted, do not recognize MHC molecules, reducing GvHD by limiting the detection of foreign antigens by surveilling immune cells. Low frequencies of MAIT, iNKT, and γδ T cells are correlated with an elevated risk of GvHD and a decreased overall survival rate in patients following allogeneic stem cell transplantation, suggesting innate T cells play a role in the modulation of GvHD in recipients of allogeneic transplants [ 28 , 43 , 92 ]. Therefore, these T-cell subtypes are receiving increasing attention to address GvHD in transplant patients.…”
Section: Discussionmentioning
confidence: 99%
“…One distinguishing characteristic that significantly contributes to their therapeutic appeal is their incapacity to induce graft-versus-host disease (GvHD) ( 105 107 ). This is attributed to their restriction by MR1 and their non-recognition of mismatched major histocompatibility complex (MHC) molecules and protein autoantigens ( 105 ).…”
Section: Role Of Mait Cells In Cancer Treatmentmentioning
confidence: 99%